Leukapheresis to obtain monocytes to produce dendritic cells for manufacturing AV-OVA-1 personal vaccines in a randomized phase II trial in patients with newly diagnosed advanced ovarian cancer

ovapuldencel-T (AVOVA-1) - Lisata Therap, AiVita Biomedical

AV-GBM-1 - AiVita Biomedical

https://jitc.bmj.com/content/10/Suppl_2/A592

James Mason 1; Lisa Abaid 2; Bradley Corr 3; Ramez Eskander 4; Fabio Cappuccini 5; Richard Friedman 6; Rockelle Robles 7; Katrina Lopez 7; Gabriel Nistor 7; Robert Dillman 7

Oct 6, 2022